FR2758264B1 - DRUG COMPOSITIONS CONTAINING EDTA OR A DERIVATIVE THEREOF FOR THE PREVENTION OF SKIN TOXICITY AND SUBCUTANEOUS ANTHRACYCLINES AND DERIVATIVES THEREOF - Google Patents

DRUG COMPOSITIONS CONTAINING EDTA OR A DERIVATIVE THEREOF FOR THE PREVENTION OF SKIN TOXICITY AND SUBCUTANEOUS ANTHRACYCLINES AND DERIVATIVES THEREOF

Info

Publication number
FR2758264B1
FR2758264B1 FR9700602A FR9700602A FR2758264B1 FR 2758264 B1 FR2758264 B1 FR 2758264B1 FR 9700602 A FR9700602 A FR 9700602A FR 9700602 A FR9700602 A FR 9700602A FR 2758264 B1 FR2758264 B1 FR 2758264B1
Authority
FR
France
Prior art keywords
anthracyclines
subcutaneous
derivative
prevention
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9700602A
Other languages
French (fr)
Other versions
FR2758264A1 (en
Inventor
Charles Dumontet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9700602A priority Critical patent/FR2758264B1/en
Publication of FR2758264A1 publication Critical patent/FR2758264A1/en
Application granted granted Critical
Publication of FR2758264B1 publication Critical patent/FR2758264B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
FR9700602A 1997-01-16 1997-01-16 DRUG COMPOSITIONS CONTAINING EDTA OR A DERIVATIVE THEREOF FOR THE PREVENTION OF SKIN TOXICITY AND SUBCUTANEOUS ANTHRACYCLINES AND DERIVATIVES THEREOF Expired - Fee Related FR2758264B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9700602A FR2758264B1 (en) 1997-01-16 1997-01-16 DRUG COMPOSITIONS CONTAINING EDTA OR A DERIVATIVE THEREOF FOR THE PREVENTION OF SKIN TOXICITY AND SUBCUTANEOUS ANTHRACYCLINES AND DERIVATIVES THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9700602A FR2758264B1 (en) 1997-01-16 1997-01-16 DRUG COMPOSITIONS CONTAINING EDTA OR A DERIVATIVE THEREOF FOR THE PREVENTION OF SKIN TOXICITY AND SUBCUTANEOUS ANTHRACYCLINES AND DERIVATIVES THEREOF

Publications (2)

Publication Number Publication Date
FR2758264A1 FR2758264A1 (en) 1998-07-17
FR2758264B1 true FR2758264B1 (en) 1999-03-26

Family

ID=9502830

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9700602A Expired - Fee Related FR2758264B1 (en) 1997-01-16 1997-01-16 DRUG COMPOSITIONS CONTAINING EDTA OR A DERIVATIVE THEREOF FOR THE PREVENTION OF SKIN TOXICITY AND SUBCUTANEOUS ANTHRACYCLINES AND DERIVATIVES THEREOF

Country Status (1)

Country Link
FR (1) FR2758264B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19818802A1 (en) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stable mitoxantron solutions useful for cancer therapy
ATE265215T1 (en) 1999-03-12 2004-05-15 Antianthra Aps DEXRAZOXANE FOR THE TREATMENT OF ADVERSE EXTRAVASATION OF ANTHRAZYCLINES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331648A (en) * 1979-12-05 1982-05-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US5242901A (en) * 1988-01-27 1993-09-07 New York University Reduction of anthracycline induced cardiotoxicity
US5162366A (en) * 1990-01-26 1992-11-10 Nissan Chemical Industries, Ltd. Antioxidant composition in vivo comprising enol form δ-lactone of diketogulonic acid
EP0705601B1 (en) * 1994-10-04 2000-01-19 LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik Anthraquinones containing solutions for parenteral administration

Also Published As

Publication number Publication date
FR2758264A1 (en) 1998-07-17

Similar Documents

Publication Publication Date Title
DZ2453A1 (en) Pharmaceutical composition for oral administration of a n-pipendin-3-pyrazolecarboxamide derivative of its salts and their solvates.
DZ2361A1 (en) 6-phenylpyridyl-2-amine derivatives and pharmaceutical compositions containing them
FR2761265B1 (en) PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF A DERIVATIVE OF N-PIPERIDINO-3-PYRAZOLECARBOXAMIDE, ITS SALTS AND THEIR SOLVATES
DZ2461A1 (en) New arylkylamine derivatives and pharmaceutical composition containing them.
DZ2086A1 (en) Substituted benzylaminopiperidines and pharmaceutical compositions containing them.
HUS1200028I1 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
TNSN97015A1 (en) NEW 19-NOR-PREGNENE DERIVATIVES.
ITRM910696A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL APPLICATION.
HUP9900881A3 (en) 4,5-diaryl oxazole derivatives and pharmaceutical compositions containing them
MA26568A1 (en) COMBINATION OF AN ALDOSE-REDUCTASE INHIBITOR AND A GLYCOGENE PHOSPHORYLASE INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
DZ2494A1 (en) Pharmaceutical composition of omeprazole.
DZ2594A1 (en) Novel 2-aminopyridine derivatives and pharmaceutical compositions containing them.
ITMI951021A0 (en) PHARMACEUTICAL AND/OR DIETARY COMPOSITIONS WITH ANTIOXIDANT ACTIVITY
FR2677984B1 (en) N-SUBSTITUTED IMIDAZOLINE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
IL112558A (en) Neuroprotective pharmaceutical compositions of 4 phenylpinene derivatives and certain novel 4 phenylpinene compounds
MA26507A1 (en) AEROSOL PHARMACEUTICAL COMPOSITIONS
FR2749583B1 (en) NOVEL SUBSTITUTED THIAZOLIDINE -2,4- DIONE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
TR199600499A2 (en) S (+) - Oral formulations of Etodolak.
FR2687401B1 (en) 1,4-DIALKYLPIPERAZINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
FR2730995B1 (en) BI-AROMATIC COMPOUNDS DERIVED FROM AMIDE, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USES THEREOF
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
FR2678170B1 (en) ORAL COMPOSITIONS FOR THE PREVENTION OF ODONTONECROSE AND PARADENTARY DISEASE.
FR2756735B1 (en) AGENT FOR INHIBITING THE EXPRESSION OF THE ICAM-1 ADHESION PROTEIN AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2758264B1 (en) DRUG COMPOSITIONS CONTAINING EDTA OR A DERIVATIVE THEREOF FOR THE PREVENTION OF SKIN TOXICITY AND SUBCUTANEOUS ANTHRACYCLINES AND DERIVATIVES THEREOF

Legal Events

Date Code Title Description
ST Notification of lapse